| 000 | 01940nam a2200397 i 4500 | ||
|---|---|---|---|
| 001 | ebr10856569 | ||
| 003 | CaPaEBR | ||
| 007 | cr cn||||||||| | ||
| 008 | 140416t20142014gw a ob 000 0 eng d | ||
| 020 | _z9783954891870 | ||
| 020 | _z9783954896875 (PDF) | ||
| 040 |
_aCaPaEBR _beng _erda _epn _cCaPaEBR |
||
| 035 | _a(OCoLC)878147377 | ||
| 050 | 1 | 4 |
_aRS189 _b.O863 2014eb |
| 082 | 0 | 4 |
_a572 _223 |
| 100 | 1 |
_aOsmane, Malik, _eauthor. |
|
| 245 | 1 | 0 |
_aRift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account / _cMalik Osmane. |
| 264 | 1 |
_aHamburg, Germany : _bAnchor Academic Publishing, _c2014. |
|
| 264 | 4 | _c�2014 | |
| 300 |
_a1 online resource (283 pages) : _billustrations (some color) |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_acomputer _2rdamedia |
||
| 338 |
_aonline resource _2rdacarrier |
||
| 504 | _aIncludes bibliographical references. | ||
| 588 | _aDescription based on online resource; title from PDF cover (ebrary, viewed April 15, 2014). | ||
| 590 | _aElectronic reproduction. Palo Alto, Calif. : ebrary, 2014. Available via World Wide Web. Access may be limited to ebrary affiliated libraries. | ||
| 650 | 0 | _aBiological products. | |
| 650 | 0 |
_aDrugs _xGeneric substitution. |
|
| 650 | 0 | _aPharmaceutical biotechnology industry. | |
| 655 | 0 | _aElectronic books. | |
| 776 | 0 | 8 |
_iPrint version: _aOsmane, Malik. _tRift-lines within European regulatory framework for biosimilars when taking heterogeneity and variation during lifecycle of the reference biologic and the biosimilar into account. _dHamburg, Germany : Anchor Academic Publishing, c2014 _h12 pages _z9783954891870 |
| 797 | 2 | _aebrary. | |
| 856 | 4 | 0 |
_uhttp://site.ebrary.com/lib/kliuc/Doc?id=10856569 _zAn electronic book accessible through the World Wide Web; click to view |
| 942 |
_2lcc _cEBK |
||
| 999 |
_c186532 _d186532 |
||